PennyMac Financial Services, Inc. — Q3 2022 Form 10-Q
Reporting period: Quarter and nine months ended September 30, 2022. Unaudited results; comparisons are with the corresponding 2021 periods unless noted. PFSI operates mortgage loan production, servicing, and investment management businesses, including services for PennyMac Mortgage Investment Trust (PMT).
Key financial results
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Total net revenue | $476.3 million | $786.6 million | $1.645 billion | $2.474 billion |
| Income before taxes | $185.5 million | $339.5 million | $597.5 million | $1.125 billion |
| Net income | $135.1 million | $249.3 million | $437.9 million | $830.4 million |
| Diluted EPS | $2.46 | $3.80 | $7.69 | $11.98 |
| Net income / revenue | 28.4% | 31.7% | 26.6% | 33.6% |
- Revenue and earnings: Q3 revenue fell about 39% and net income about 46%. Lower loan-production gains and fees were partly offset by stronger servicing results. Nine-month revenue declined about 34% and net income about 47%.
- Production and servicing: Q3 net gains on loans held for sale were $168.7 million, down from $626.8 million. Net loan servicing fees rose to $243.7 million from $33.6 million, including improved MSR valuation results net of hedging. Q3 production-segment pretax income was $38.6 million versus $330.6 million; servicing pretax income was $145.3 million versus $8.0 million.
- Cash flow: Nine-month operating cash flow was $5.544 billion, versus $2.770 billion; investing used $483.6 million and financing used $3.842 billion. Cash and restricted cash increased $1.219 billion to $1.559 billion. Operating cash flow is substantially affected by mortgage-loan inventory movements and should not be read as recurring earnings.
- Balance sheet and debt: At September 30, cash and short-term investments were $1.595 billion; total assets were $16.362 billion; stockholders’ equity was $3.482 billion. Debt reported in MD&A was $7.428 billion ($3.855 billion short-term and $3.573 billion long-term), down from $10.850 billion at year-end 2021. Debt-to-equity declined to 2.1x from 3.2x. Separately, $3.758 billion of loans eligible for repurchase had an equal liability.
- Liquidity: Available borrowing capacity under repurchase facilities was reported at $6.135 billion, including $801 million committed and $5.334 billion uncommitted. Agency-reported actual liquidity was $1.546 billion, compared with stated requirements of $103.8 million for Fannie Mae/Freddie Mac and $239.2 million for Ginnie Mae. The company reported compliance with financing covenants and Agency requirements.
Material changes and management commentary
- Management attributed weaker production results to higher interest rates, lower mortgage demand, reduced origination volumes, lower gain-on-sale margins, and lower early-buyout loan redelivery gains. The filing cites an external 2022 mortgage-origination forecast of $2.4 trillion, compared with $4.4 trillion in 2021.
- Expenses declined as staffing and production-related costs were reduced. Compensation expense fell by $91.4 million in Q3; period-end headcount was 4,732, versus 7,261 a year earlier. Management said it had reduced expenses and expected to continue aligning costs with lower projected production.
- The servicing portfolio grew to $539.1 billion UPB from $509.7 billion at year-end 2021. MSRs increased to $5.662 billion from $3.878 billion, supported in part by loan-sale additions and higher rates reducing expected prepayments. Q3 MSR hedging losses were $164.7 million; nine-month losses were $558.6 million.
- Q3 net interest income was nearly breakeven at $29,000, versus $22.4 million of net interest expense a year earlier. Higher custodial-fund placement income and lower loan-payoff interest shortfalls helped offset lower loan-inventory interest income and higher borrowing costs.
- No specific earnings or EPS guidance was provided. The filing warns that rising rates may further reduce production, increase floating-rate funding costs, and affect asset values; slower prepayments can benefit MSRs but outcomes depend on market conditions and hedging.
Risks, contingencies, and notable items
- Fair-value sensitivity: MSRs are largely Level 3 fair-value assets. At September 30, a 10% adverse change in modeled prepayment speed, pricing spread, or servicing cost was estimated to reduce MSR fair value by approximately $147.7 million, $159.3 million, or $76.3 million, respectively. These sensitivities are not earnings forecasts.
- Funding and market risk: Repurchase facilities have short maturities and margin-call provisions; collateral-value declines can require rapid cash or asset transfers. Much of the company’s financing is floating-rate. Management said facilities maturing before the report date were renewed or extended.
- Loan repurchases and representations: The representations-and-warranties liability was $37.2 million. Management expects higher rates and a potential slowdown could increase defaults and repurchase losses, while stating the recorded liability was adequate.
- Regulatory and legal matters: A CFPB enforcement review concerning alleged historical RESPA and TILA violations remained open; PFS said the alleged violations had been remediated and did not expect a material adverse effect. A Black Knight trade-secrets and contract dispute remained pending in arbitration; PFS said it believed the claims were without merit. Management did not expect ordinary-course litigation to have a material adverse effect.
- Other: The company identified LIBOR transition uncertainty and dependence on Agencies and PMT among relevant risks. Revised Agency capital and liquidity requirements begin taking effect from September 30, 2023. The filing reported no material change to the risk factors in the 2021 Form 10-K and no off-balance-sheet arrangements.
- Capital returns: PFS repurchased 1.949 million shares for $99.7 million in Q3; $334.6 million remained under the $2 billion authorization at quarter-end. It declared a $0.20-per-share dividend payable November 23, 2022.
Important facts for investors to verify
- Whether lower mortgage production and gain-on-sale margins continue, and whether cost reductions can keep pace without impairing operations.
- How MSR fair-value gains, servicing cash flows, and hedge results evolve as rates and prepayment expectations change.
- Liquidity available under committed facilities, renewal terms for short-term funding, margin-call exposure, and compliance with debt and Agency covenants.
- Actual repurchase and indemnification losses compared with the $37.2 million representations-and-warranties reserve.
- Developments in the CFPB review, Black Knight arbitration, LIBOR transition, and revised Agency requirements.
- Whether buybacks and dividends remain supportable given earnings, liquidity needs, and mortgage-market conditions.